Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.
Saved in:
| Title: | Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study. |
|---|---|
| Authors: | Baruchel A; Robert Debré University Hospital (APHP and Université Paris Cité) Paris France., Nysom K; Department of Paediatrics & Adolescent Medicine Copenhagen University Hospital-Rigshospitalet Copenhagen Denmark., Kang HJ; Department of Pediatrics Seoul National University Cancer Research Institute, Wide River Institute of Immunology, Seoul National University College of Medicine, Seoul National University Children's Hospital Seoul Korea., Felice MS; Hematology and Oncology Department Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Buenos Aires Argentina., Michalowski MB; Hospital de Clínicas de Porto Alegre, Unidade de Pesquisa em Hematologia Porto Alegre Rio Grande do Sul Brazil., Freigeiro D; Hospital de Niños Ricardo Gutierrez Capital Federal Buenos Aires Argentina., Epelman S; Hospital Santa Marcelina São Paulo São Paulo Brazil., Lopes de Sousa AV; Grupo de Apoio à Criança e ao Adolescente com Câncer-GRAACC/UNIFESP São Paulo São Paulo Brazil., Valera ET; Unidade de Pesquisa Clínica do HC FMRP-USP, Hospital da Clínicas Ribeirão Preto Ribeirão Preto São Paulo Brazil., Moreira L; Fundacao Dr Amaral Carvalho-Hospital Dr Amaral Carvalho Jau São Paulo Brazil., Leverger G; INSERM, Centre de Recherche Saint-Antoine, UMR-S938, AP-HP, Groupe Hospitalier Sorbonne Université, Hôpital Armand Trousseau APHP Sorbonne Université Paris France., Nelken B; CHU de Lille, Hôpital Jeanne de Flandre Lille France., Kattamis A; Pediatric Hematology-Oncology Unit, First Department of Pediatrics National and Kapodistrian University of Athens Athens Greece., Rizzari C; Pediatric Haematology Oncology Unit, Foundation IRCCS San Gerardo dei Tintori University of Milano-Bicocca Monza Italy., Fagioli F; Ospedale Regina Margherita Centro Torino Italy., Cesaro S; Pediatric Hematology Oncology Azienda Ospedaliera Universitaria Integrata Verona Verona Italy., González-Llano O; Madero y Gonzalitos S/N, Col. Mitras Centro Monterrey Nuevo León Mexico., Buechner J; Department of Pediatric Hematology and Oncology Oslo University Hospital Oslo Norway., Choque WQ; Centro Médico Monte Carmelo Arequipa Peru., Duarte J; Pediatric Oncology Department Instituto Português de Oncologia de Lisboa Lisbon Portugal., Abrahamsson J; Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska University Hospital University of Gothenburg Gothenburg Sweden., Alarcón A; Hematology and Oncology Department Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Buenos Aires Argentina., Wang L; Sanofi Cambridge Massachusetts United States., Macé S; Sanofi Vitry-sur-Seine France., Oprea C; Sanofi Vitry-sur-Seine France., Abbadessa G; Sanofi Cambridge Massachusetts United States.; Present address: ModeX Therapeutics Weston Massachusetts USA., Zwaan CM; Princess Máxima Centre for Pediatric Oncology Utrecht The Netherlands.; Department of Pediatric Oncology Erasmus MC-Sophia Children's Hospital Rotterdam The Netherlands. |
| Source: | HemaSphere [Hemasphere] 2025 Oct 30; Vol. 9 (10), pp. e70245. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70245 |
